Last reviewed · How we verify
NCT05648331
Wheelchair Use in Patients With Amputation
trial in Amputation, Wheelchair in 100 participants. Status unknown.
28 February 2023
Quick facts
| Lead sponsor | Gaziler Physical Medicine and Rehabilitation Education and Research Hospital |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 10 January 2023 |
| Primary completion | 28 February 2023 |
| Estimated completion | 30 March 2023 |
| Sites | 1 location across Turkey (Türkiye) |
Conditions studied
- Amputation, Wheelchair — all drugs for Amputation, Wheelchair →
Sponsor
Gaziler Physical Medicine and Rehabilitation Education and Research Hospital
Who can join
Adults 18 to 65, any sex, with Amputation, Wheelchair. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
There are no specific criteria for wheelchair use in patients with lower extremity amputations. The main purpose of this study is to determine the characteristics of wheelchair use in lower extremity amputee patients. In addition, it is aimed to determine the reasons for using and not using a wheelchair, and what type of wheelchair is needed.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05648331
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Gaziler Physical Medicine and Rehabilitation Education and Research Hospital trials
Trials by the same sponsor.
- NCT07207694 — WhatsApp-Based Education Program for Stroke Patients · NA · not yet recruiting
- NCT07472543 — Impact of Virtual Reality (VR) Based Exercises on Lower Limb Lymphedema Outcomes (LELO) · NA · recruiting
- NCT07507357 — Tidal Model Nursing for TBI Caregivers · NA · completed
- NCT07059468 — Osteoporosis After Stroke · completed
- NCT06917027 — Comparison of Mobile Education and Face-to-Face Intermittent Catheterization Education · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05648331 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Gaziler Physical Medicine and Rehabilitation Education and Research Hospital
- Last refreshed: 3 January 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05648331.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing